Eurofins Genomics offers comprehensive biopharma services designed to support pharmaceutical and biotechnology industries in their research, development, and production efforts. With cutting-edge technology, including Sanger sequencing and Next Generation Sequencing (NGS), we ensure precise, reliable data to meet the growing needs of the biopharma sector.

Our services

Cell line identification

By utilising Sanger sequencing, we help to ensure the authenticity and integrity of cell lines. Our precise identification methods safeguard against cross-contamination and misidentification, supporting reliable research outcomes.

Microbial identification (MID)

MID services provide accurate detection of microorganisms critical for research, development, and production. Eurofins Genomics uses advanced genomic techniques to identify microbial species efficiently.

Pharmacogenomics

We deliver deep insights into the relationship between an individual's genetic makeup and drug response. We offer:

  • Whole genome sequencing
  • Exome sequencing of the human genome
  • Targeted SNP sequencing using ABI3730xl sanger sequencing
  • SNP association testing for drug response
  • Identification of SNP biomarkers associated with diseases and their correlation with phenotype across animal models and humans

Microbial cell bank testing

We provide thorough testing of microbial cell banks, offering:

  • Mapping on the reference or insert sequence
  • Flanking sequence identification (using NGS or sanger primer walking)
  • Identification of sequence variations
  • Comparative analysis between master and working cell banks

RNA-Seq for clinical trials

RNA-Seq analysis plays a key role in assessing drug treatments and identifying gene targets in clinical trials. This service helps streamline drug development by analysing gene expression to understand the effects of drugs at a molecular level.

Master & working seed stock testing

Ensure genomic stability with our master and working seed stock testing. These services demonstrate the stability of genotypes following passages and include:

  • Whole genome sequencing
  • SNP discovery and annotation
  • Genomic sequence comparison between master and working seed stock
  • Insert characterisation of biologic genes

Drug discovery next-generation sequencing

NGS is integral to the discovery of new genomic biomarkers, mutation detection, and personalized medicine. Our services include:

  • Genome-wide association studies
  • Whole genome sequencing
  • Exome sequencing of the human genome
  • Targeted SNP sequencing through high-throughput Sanger sequencing

Identification of Adventitious Agents

We offer adventitious agent identification services, crucial for the safety and effectiveness of biopharmaceuticals:

  • 16S/ITS analysis
  • Shotgun metagenomics for the detection of unintended microorganisms

Find a site near you!

Clear Filters
Reset Filters
Getting the map ready...